M, S., & G, S. (2011). Combination therapy versus celecoxib, a single selective COX-2 agent, to reduce gastrointestinal toxicity in arthritic patients: Patient and cost-effectiveness considerations. Dove Medical Press.
Chicago Style (17th ed.) CitationM, Scolnik, and Singh G. Combination Therapy Versus Celecoxib, a Single Selective COX-2 Agent, to Reduce Gastrointestinal Toxicity in Arthritic Patients: Patient and Cost-effectiveness Considerations. Dove Medical Press, 2011.
MLA (8th ed.) CitationM, Scolnik, and Singh G. Combination Therapy Versus Celecoxib, a Single Selective COX-2 Agent, to Reduce Gastrointestinal Toxicity in Arthritic Patients: Patient and Cost-effectiveness Considerations. Dove Medical Press, 2011.
Warning: These citations may not always be 100% accurate.